Footnotes

• For correspondence: Dr Eduard Vieta, Director of Research, Clinical Institute of Neuroscience, Hospital, Clinic, University of Barcelona, Barcelona, Spain; evieta{at}clinic.ub.es

• Sources of funding: Bristol-Myers Squibb Company, Princeton, New Jersey, USA and Otsuka Pharmaceutical Co Ltd, Tokyo, Japan